PeptideStack
5.2kquestions
20kanswers
220users

How many freeze-thaw cycles will orforglipron at 5 mg/mL tolerate?

Asked 28 Dec 2025Modified 5 months agoViewed 15k times
22

Stated plainly: orforglipron · 5 mg/mL.

This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.

What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.

What would you do, and what would you check afterwards?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
shareeditfollowflag
BB
askedbac_or_bust33k13728 Dec 2025
4Same question here after a warm delivery, so I am following this. – ines_delacruz 8 months ago
3Worth saying whether the vial has been opened, because that starts a different clock. – plate_count_9k 7 months ago
add a comment

2 Answers

Accepted answer first, then by votes
-2

Accepted answer

Nobody has published a cycle count, and at 5 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.5 mg and every microlitre is 5 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 5 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 5 mg/mL and the date, and never thaw a container you will refreeze.

This is one of the few handling questions with a genuinely quantitative literature behind it.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.

Dry powder tolerates cycles far better than solution does.

edited 13 Mar 2026 by Dr_Otto_Lindqvist — updated for the 2026 guidance change

shareimprove this answerflag
DL
answered · acceptedDr_Otto_Lindqvist72k586 Mar 2026
4Adding a vote because this deserves more of them. – n_takahashi 6 months ago
3Does the same reasoning apply to material already in solution, or is that a different curve? – anouk_desmet 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
22

The short version: aliquot before freezing, thaw slowly, never refreeze a thawed aliquot, and count your cycles.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

On the detail: a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Let a frozen vial reach room temperature before opening, or you condense water into it.

shareimprove this answerflag
C8
answeredcoldpack_8850k371 Mar 2026
6Worth adding that residual moisture predicts this better than any printed date. – Dr_Nadia_Farsi 44 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.